Talking Cybersecurity with Mariano Mattei (INTERPHEX 2023)

Article
Conference|INTERPHEX

Mariano Mattei, vice-president of cybersecurity and CISO for Azzur Group, goes in depth about cybersecurity in the pharma field.

Mariano Mattei, vice-president of cybersecurity and CISO for Azzur Group, goes in depth about cybersecurity in the pharma field, including FDA guidelines concerning cybersecurity, best practices, and addressing concerns companies may have.

For more INTERPHEX 2023 video content, check this page for updates.

Recent Videos
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Circio and Certest to Collaborate on LNP Formulations

Feliza Mirasol
November 21st 2024
Article

The companies will collaborate to create and test circVec DNA–LNP formulations for use in potential therapeutic applications.

Drug Solutions Podcast: Examining the State of Biopharma Investment

Drug Solutions Podcast: Examining the State of Biopharma Investment

Grant Playter
June 6th 2023
Podcast

In this episode, Siegfried Schmitt, vice president, Technical at Parexel, discusses the state of biopharma investment in 2023.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Avid Bioservices Acquired by GHO Capital Partners and Ampersand Capital Partners

Susan Haigney
November 7th 2024
Article

The merger agreement is valued at approximately $1.1 billion.

How Changing Regulations Impact Pharmaceutical Film Coating Formulations (AAPS 2022)

How Changing Regulations Impact Pharmaceutical Film Coating Formulations (AAPS 2022)

Chris Spivey
November 29th 2022
Podcast

Allison Labriola, Senior Technical Sales Representative, at JRS Pharma is interviewed by the Editorial Director of Pharmaceutical Technology Chris Spivey about how the food industry is affecting the pharmaceutical industry.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Denmark’s First AI Supercomputer for Drug Discovery Now Operational Under Novo Nordisk Foundation Commitment

Feliza Mirasol
November 1st 2024
Article

With DKK 600 million (US$87.4 million) in funding from the Novo Nordisk Foundation, the new supercomputer offers the potential to accelerate innovation in drug discovery.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Novartis and Monte Rosa Therapeutics Form $2.1 Billion Global License Agreement for MGD-based Therapeutics

Feliza Mirasol
October 29th 2024
Article

The collaboration aims to advance clinical development of a Phase I drug candidate, MRT-6160, and to explore other therapeutic opportunities across multiple indications.